Wolverine Asset Management’s Boston Scientific BSX Stock Holding History

Wolverine Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-57,333	Closed	-$2.14M	–	2397
2022 Q2	$2.14M	Buy	57,333 +20,346	+55%	+$828K	0.02%	536
2022 Q1	$1.64M	Buy	36,987 +17,094	+86%	+$741K	0.02%	573
2021 Q4	$845K	Buy	+19,893	New	+$836K	0.01%	852
2021 Q3	–	Sell	-12,402	Closed	-$530K	–	2015
2021 Q2	$530K	Sell	12,402 -11,026	-47%	-$464K	﹤0.01%	879
2021 Q1	$905K	Sell	23,428 -342,825	-94%	-$13M	0.01%	686
2020 Q4	$13.2M	Buy	366,253 +306,430	+512%	+$11M	0.1%	168
2020 Q3	$2.29M	Buy	59,823 +59,269	+10,698%	+$2.28M	0.02%	379
2020 Q2	$19K	Buy	+554	New	+$20K	﹤0.01%	1368
2019 Q2	–	Sell	-2,902	Closed	-$111K	–	1412
2019 Q1	$111K	Buy	+2,902	New	+$111K	﹤0.01%	1105
2014 Q3	–	Sell	-4,700	Closed	-$59.2K	–	2457
2014 Q2	$60K	Buy	+4,700	New	+$61.1K	﹤0.01%	1318
2014 Q1	–	Sell	-30,000	Closed	-$394K	–	2460
2013 Q4	$360K	Sell	30,000 -100	-0.3%	-$1.18K	0.01%	900
2013 Q3	$353K	Buy	30,100 +29,100	+2,910%	+$315K	0.01%	898
2013 Q2	$9K	Buy	+1,000	New	+$8.48K	﹤0.01%	2231

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wolverine Asset Management's BSX Position: Q3 2022 in Review

Wolverine Asset Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 57,333 shares — an estimated $2.14M sold.

Wolverine Asset Management first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $13.2M in Q4 2020. 866 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Wolverine Asset Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
Wolverine Asset Management sold 57,333 Boston Scientific shares in Q3 2022, an estimated $2.14M.
Wolverine Asset Management first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
Wolverine Asset Management's Boston Scientific position peaked at $13.2M in Q4 2020.
866 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.